Regulation of the epithelial sodium channel (ENaC) is highly complex and may involve several aldosterone-induced regulatory proteins. The N-Myc downstream-regulated gene 2 (NDRG2) has been identified as an early aldosterone-induced gene. Therefore, we hypothesized that NDRG2 may affect ENaC function. To test this hypothesis we measured the amiloridesensitive (2 M) whole cell current (⌬I ami ) in Xenopus laevis oocytes expressing ENaC alone or co-expressing ENaC and NDRG2. Co-expression of NDRG2 significantly increased ⌬I ami in some, but not, all batches of oocytes tested. An inhibitory effect of NDRG2 was never observed. Using a chemiluminescence assay we demonstrated that the NDRG2-induced increase in ENaC currents was accompanied by a similar increase in channel surface expression. The stimulatory effect of NDRG2 was preserved in oocytes maintained in a low sodium bath solution to prevent sodium feedback inhibition. These findings suggest that the stimulatory effect of NDRG2 is independent of sodium feedback regulation. Furthermore, the stimulatory effect of NDRG2 on ENaC was at least in part additive to that of Sgk1. A short isoform of NDRG2 also stimulated ⌬I ami . Overexpression of NDRG2 and ENaC in Fisher rat thyroid cells confirmed the stimulatory effect of NDRG2 on ENaC-mediated short-circuit current (I SC-ami ). In addition, small interference RNA against NDRG2 largely reduced I SC-ami in Fisher rat thyroid cells. Our results indicate that NDRG2 is a likely candidate to contribute to aldosterone-mediated ENaC regulation.The epithelial sodium channel (ENaC) 2 consists of three subunits (␣, , and ␥) and is localized in the apical membranes of sodium absorbing epithelia like the aldosterone-sensitive distal nephron, respiratory epithelia, distal colon, sweat, and salivary ducts. It is the rate-limiting step for sodium absorption in these epithelia and plays a major role in the maintenance of body sodium balance (1, 2). The appropriate regulation of ENaC is critically important for the long term control of arterial blood pressure (3). This is evidenced by gain-of-function mutations of ENaC causing Liddle syndrome (pseudohyperaldosteronism), a hereditary form of severe arterial hypertension (4). In contrast, loss-of-function mutations of ENaC cause pseudohypoaldosteronism type 1, a salt-wasting syndrome with low blood pressure (5).The main hormonal regulator of ENaC is aldosterone (1, 2). It is well accepted that aldosterone increases ENaC expression in the apical membrane of principal cells in the aldosteronesensitive distal nephron (6 -9). In addition an increase in channel open probability and the activation of near-silent channels are mechanisms involved in ENaC activation by aldosterone (1, 10). The aldosterone response has a characteristic time course. During the so-called "early response" (1.5-3 h) the predominant effect is an activation of pre-existing Na ϩ channels and pumps. This is followed by a "late response" (6 -24 h) characterized by the transcriptional and translational up-regulation of the...